Adhesive volume growth 15-20% for FY24
Management expects adhesive business to grow 15-20% in volume terms for the full year, with EBITDA margin above 15%.
Astral · forward-looking guidance across the available source record.
Guidance tracker
Management expects adhesive business to grow 15-20% in volume terms for the full year, with EBITDA margin above 15%.
CFO guided that pipe EBITDA per kg should be in the range of INR 35-40 for the year, excluding inventory and bathware losses.
Capital expenditure for capacity expansion is expected to be around INR 350 crore in FY24 and INR 250 crore in FY25.
The demerged paint entity will operate under the Astral Synergy brand, with full operations expected from Q3 FY24.
Management reiterated its 15%+ volume growth guidance for the full year, with potential upside if H2 performs well.
Management guided for plumbing EBITDA margin in the range of 16%-18% for the full year.
Management expects to maintain 16% EBITDA margin in India adhesives for the full year.
Management guided for capital expenditure of approximately INR 350 crore for the full year.
Management is confident of achieving double-digit volume growth for the full year, supported by improving demand from July onwards.
Bathware aims to sustain similar growth momentum in coming quarters, targeting 27% growth.
Paint business targets minimum 20% top-line growth for the full year, reaching around INR 240 crore run rate.
The 40,000 MT CPVC resin plant will be commissioned by Q2 FY2027, with total investment of INR 150 crore (Astral's share INR 120 crore).
Management increased full-year volume growth guidance from 15% to over 20% for the pipes business, driven by strong H1 performance and demand outlook.
Bathware segment expected to reach breakeven within the next two quarters as monthly sales cross ₹10 crore.
Management reiterated long-term guidance of 15-20% annual growth for the adhesive segment, with potential upside from Dahej ramp-up.
Capital expenditure for FY25 expected to be ₹250-300 crore, lower than FY24 due to land acquisitions already completed.
Management expects 10-15% volume growth in pipes for FY25, with a stretch target of 15% if restocking materializes.
Management reiterated consolidated EBITDA margin guidance of 15-16%, with pipes at 16-18% and adhesives India at 15%.
Bathware vertical is on track to achieve full-year revenue of INR 100-125 crore, with monthly run rate already at INR 10 crore.
Management targets over INR 100 crore revenue from OPVC in the first full year of commercial production, with three machines installed.
Management reaffirmed guidance of double-digit volume growth for the full year, with H2 expected to be stronger than H1.
The UK business is expected to return to double-digit EBITDA margins by FY2027, with substantial improvement by March 2026.
Management guided that the paint segment will reach single-digit EBITDA margins by FY2027, up from current pressure.
The 40,000 MTPA CPVC plant construction will start next month, with commissioning targeted by September 2026.
Management revised guidance to 20%+ volume growth for the full year; 9M already at 24%.
Guidance maintained; 9M margin at 17%+ and Q4 expected to be robust, potentially exceeding guidance.
9M margin at 16%, already surpassing guidance; full year expected to be at or above the range.
Primarily for pipe capacity expansion; other divisions' CapEx largely completed.
Management expects 10-15% volume growth in pipes next fiscal, aided by a low base and potential demand recovery post-budget.
Bathware vertical is on track to surpass the guided INR 100-120 crore revenue for FY25, with nine-month sales of INR 83 crore.
Corrective measures in UK operations are expected to restore EBITDA margins to historical 5-10% range from Q1 FY26 onward.
Capital expenditure for FY26 is guided at around INR 250 crore, significantly lower than FY25's estimated INR 450 crore.
Management expects full-year volume growth to exceed 12-13% nine-month run rate, with Q4 likely better than Q3.
Pipes EBITDA margin guided in 16-18% range; Q3 was 18.2% including inventory loss, so Q4 could be higher.
Combined margin for adhesives and paints targeted at 12-14%, though nine-month actual is 10.8% due to UK and paint losses.
Backward integration CPVC plant on schedule; trial runs in Q3 FY27, regular production by Q4 FY27.
Management guides 15-20% volume growth for pipes, with potential upward revision after H1 based on polymer price and demand trends.
Paints business targets INR 300+ crore revenue in FY25 with EBITDA margin of 14-15%, leveraging Astral brand and distribution.
Bathware business aims to achieve revenue of INR 125-150 crore and turn EBITDA positive in FY25.
Planned CapEx of INR 250 crore for pipes (Hyderabad and Kanpur plants) and INR 50 crore for other businesses, with potential increase if demand is robust.
Management expects low double-digit volume growth for pipes in FY26, aided by potential anti-dumping duty and BIS implementation.
Capital expenditure for FY26 is guided at INR 250-300 crore, mainly for Kanpur plant completion and other expansions.
Management expects UK operations to deliver positive EBITDA in FY26, with improvements visible from Q2 onwards.
Paint segment is expected to see small margin improvement in FY26 as volumes increase.